13F Holdings
中文EN

MRM Medirom Healthcare Technologies Inc. Annual reports only

Services-Personal Services · Nasdaq · SEC CIK 1819704 · Reporting currency JPY · Fiscal year ends 12/31

Financial factors as of 2024-12-31 (FY2024), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY21.5%
TTM net income YoY28.9%
TTM EPS YoY27.7%
Revenue 3-yr CAGR15.3%
Net income 3-yr CAGR—

Margins

Gross margin27.1%
Operating margin-0.2%
Net margin1.8%
FCF margin-16.9%
EBITDA margin3.3%

Returns

ROE26.0%
ROA2.0%
ROIC (approx.)-1.1%
Asset turnover1.11x

Leverage & solvency

Liabilities / assets85.3%
Debt / equity1.48x
Current ratio0.65x
Interest coverage-0.36x

Cash quality & payout

Operating cash flow / net income-8.95x
Accruals ratio19.8%
Payout ratio—
Capex / revenue0.9%

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Unit: JPY FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31FY20202020-12-31
Income statement
Revenue8.30B6.83B6.95B5.41B3.34B
Cost of revenue6.05B5.26B5.05B——
Gross profit2.25B1.57B1.90B——
SG&A expense2.24B1.96B1.81B1.82B1.07B
Operating income-18.10M-391.58M96.97M-470.59M-746.09M
Interest expense49.74M36.87M9.80M11.95M13.23M
Pretax income47.71M20.62M179.77M-414.48M-626.69M
Income tax-90.48M-94.43M30.81M576.25M-87.52M
Net income148.76M115.40M148.97M-990.73M-539.17M
EBITDA271.94M-138.98M281.02M-344.34M-683.80M
EPS (basic)29.1323.6430.54-203.13-133.97
EPS (diluted)28.5222.3427.23-203.13-133.97
Weighted avg. shares (diluted)5.85M5.17M5.47M4.88M4.02M
Balance sheet
Cash & equivalents329.40M106.35M605.45M370.62M1.44B
Short-term investments6.16M26.50M26.50M26.53M32.52M
Receivables1.36B621.87M534.69M312.30M148.54M
Inventory151.64M139.98M114.11M18.70M7.96M
Current assets2.71B1.76B2.36B1.38B2.09B
PP&E, net435.66M451.50M424.29M425.00M235.93M
Goodwill389.13M484.56M539.49M600.33M150.72M
Intangibles1.14B920.70M403.67M391.04M97.61M
Total assets8.09B6.85B6.75B5.75B5.71B
Current liabilities4.18B3.56B3.64B3.20B2.65B
Short-term debt620.81M100.42M99.17M162.25M242.28M
Long-term debt764.20M1.05B1.15B746.59M668.38M
Total debt1.39B1.15B1.25B908.84M910.66M
Total liabilities6.90B6.63B6.81B5.96B5.22B
Shareholders' equity933.27M210.88M-59.38M-208.34M491.26M
Net debt1.06B1.04B643.48M538.22M-529.07M
Shares outstanding7.90M————
Cash flow statement
Operating cash flow-1.33B-631.74M-685.70M-557.23M-366.42M
Capital expenditure71.41M135.84M120.74M95.65M73.56M
Free cash flow-1.40B-767.58M-806.44M-652.88M-439.98M
Investing cash flow361.39M-328.58M580.44M-83.94M-139.60M
Financing cash flow1.19B461.21M340.10M-427.95M1.43B
Depreciation & amortization290.04M252.59M184.06M126.24M62.29M
Stock-based compensation———196.85M—

Free plan shows the latest 5 periods; Pro shows all 6 🔒

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· Amounts are in the company's reporting currency, JPY, not USD; the site does no currency conversion.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.